Zenith Drugs Limited (NSE:ZENITHDRUG)

Zenith Drugs Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jan 23, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	806	1,230	1,075	-	-	-
Market Cap Growth	-42.79%	14.35%	-	-	-	-
Enterprise Value	1,320	1,389	1,332	-	-	-
Last Close Price	47.00	71.70	62.48	-	-	-
PE Ratio	21.37	17.17	11.27	-	-	-
PS Ratio	0.56	0.92	0.82	-	-	-
PB Ratio	1.12	1.77	1.73	-	-	-
P/TBV Ratio	1.17	1.78	1.73	-	-	-
EV/Sales Ratio	0.92	1.04	1.01	-	-	-
EV/EBITDA Ratio	9.70	9.79	7.38	-	-	-
EV/EBIT Ratio	15.92	12.38	7.96	-	-	-
Debt / Equity Ratio	0.72	0.70	0.39	1.47	1.55	1.73
Debt / EBITDA Ratio	3.81	3.43	1.33	2.64	2.75	2.20
Asset Turnover	-	0.90	1.13	1.38	1.59	1.63
Inventory Turnover	-	2.68	3.47	4.38	7.67	9.34
Quick Ratio	0.75	0.77	1.19	0.69	0.75	0.84
Current Ratio	1.44	1.45	1.76	1.17	1.15	1.20
Return on Equity (ROE)	-	10.88%	23.86%	32.71%	29.71%	39.03%
Return on Assets (ROA)	-	4.74%	9.01%	6.46%	5.98%	8.05%
Return on Invested Capital (ROIC)	4.33%	8.89%	19.85%	17.64%	15.48%	19.39%
Return on Capital Employed (ROCE)	9.80%	13.60%	23.90%	32.70%	25.00%	35.10%
Earnings Yield	4.69%	5.82%	8.87%	-	-	-
FCF Yield	-	-29.91%	-19.69%	-	-	-
Dividend Yield	-	-	0.80%	-	-	-
Buyback Yield / Dilution	70.12%	-	-42.91%	-	-	-
Total Shareholder Return	70.12%	-	-42.11%	-	-	-

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.